KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Shares Outstanding (Weighted Average): 2015-2025

Historic Shares Outstanding (Weighted Average) for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $28.1 million.

  • Medpace Holdings' Shares Outstanding (Weighted Average) fell 9.38% to $28.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.1 million, marking a year-over-year decrease of 9.38%. This contributed to the annual value of $31.1 million for FY2024, which is 1.30% up from last year.
  • Medpace Holdings' Shares Outstanding (Weighted Average) amounted to $28.1 million in Q3 2025, which was down 2.26% from $28.7 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Shares Outstanding (Weighted Average) ranged from a high of $36.0 million in Q2 2021 and a low of $28.1 million during Q3 2025.
  • For the 3-year period, Medpace Holdings' Shares Outstanding (Weighted Average) averaged around $30.4 million, with its median value being $30.7 million (2023).
  • Per our database at Business Quant, Medpace Holdings' Shares Outstanding (Weighted Average) grew by 1.69% in 2021 and then decreased by 13.47% in 2022.
  • Medpace Holdings' Shares Outstanding (Weighted Average) (Quarterly) stood at $35.9 million in 2021, then dropped by 13.47% to $31.1 million in 2022, then declined by 1.34% to $30.7 million in 2023, then increased by 1.30% to $31.1 million in 2024, then fell by 9.38% to $28.1 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $28.1 million for Q3 2025, versus $28.7 million for Q2 2025 and $30.5 million for Q1 2025.